Journal
CLINICAL OPHTHALMOLOGY
Volume 13, Issue -, Pages 2341-2352Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/OPTH.S220845
Keywords
central serous chorioretinopathy; acute central serous chorioretinopathy; chronic central serous chorioretinopathy
Categories
Ask authors/readers for more resources
Central serous chorioretinopathy (CSC) is a common retina disease and has a relative high recurrence rate, etiology, and pathogenesis of which remains largely ambiguous. The effects on the retina are usually self-limited, although some people are left with permanent vision loss due to progressive and irreversible photoreceptor damage or retinal pigment epithelium atrophy. There have been a number of interventions used in CSC, including, but not limited to, laser treatment, photodynamic therapy (PDT), intravitreal injection of anti-vascular endothelial growth factor agents, and subthreshold lasers. It is not clear whether there is a clinically important benefit to treating acute CSC, which often resolves spontaneously as part of its natural history. Of the interventions studied to date, PDT and micropulse laser treatment appear the most promising.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available